SK pharmteco
Min Soo Hong has a solid work experience in various roles and companies. Min Soo started their career as a Junior Manager at SK Engineering & Construction Co. Ltd in 2004 and worked there until 2010. Min Soo then joined SK as a Project Leader and worked in that role until 2017. From 2017 to 2021, they served as the Chief Financial Officer at SK biotek Ireland, which is an SK pharmteco company. Currently, they are working as the Vice President Finance at SK pharmteco, starting in April 2021.
Min Soo Hong completed their Master of Business Administration (MBA) degree with a focus on Finance from Hankuk University of Foreign Studies in 2021. Prior to that, they obtained a Bachelor's degree in History/Journalism & Mass Communication from Hanyang University, which they attended from 1997 to 2004. Additionally, they attended Seoul High School from 1993 to 1996.
SK pharmteco
Headquartered in Rancho Cordova, California, SK pharmteco is a global contract development and manufacturing organization specializing in the production of active pharmaceutical ingredients (APIs), advanced intermediates, and cell and gene therapy for the pharmaceutical industry. Built on 80 years of experience, our global operations have the capability and capacity to support client needs from development through commercial production. SK pharmteco is owned by SK Inc., the strategic investment arm of South Korea’s SK Group.